-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Immix Biopharma, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2022 to Q3 2025.
- Immix Biopharma, Inc. Return On Equity for the quarter ending September 30, 2025 was -264 %, a 157% decline year-over-year.
- Immix Biopharma, Inc. annual Return On Equity for 2024 was -105 %, a 3.41% decline from 2023.
- Immix Biopharma, Inc. annual Return On Equity for 2023 was -102 %, a 109% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)